Allied Market Research

2024

Colon Cancer Diagnostic Tests Market

Colon Cancer Diagnostic Tests Market Size, Share, Competitive Landscape and Trend Analysis Report by Test and by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Diagnostics and Biotech

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Colon Cancer Diagnostic Tests Market Report Highlights

Aspects Details
icon_5
By Test
  • FECAL OCCULT BLOOD TESTS (FOBT)
  • BIOMARKER TESTS
icon_6
By End User
  • Hospitals
  • CLINICAL DIAGNOSTIC LABORATORIES
  • PHYSICIANS’ OFFICE LABORATORIES
  • HOME TEST KIT
icon_7
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
icon_8
Key Market Players

Novartis AG, Cepheid Inc., Biocartis Group NV, Epic Sciences, Inc., Hologic, Inc., Exact Sciences Corporation, Quest Diagnostics Incorporated, Guardant Health, Inc., Abbott Laboratories, Roche Diagnostics

Loading Table Of Content...

Colon Cancer Diagnostic Tests Market

Global Opportunity Analysis and Industry Forecast, 2023-2032